-
1
-
-
24644480633
-
Graft-vs-host disease after nonmyeloablative hematopoietic cell transplantation
-
Mielcarek M, Storb R. Graft-vs-host disease after nonmyeloablative hematopoietic cell transplantation. Leuk Lymphoma 2005; 46:1251-1260. An update of clinical outcome in nonmyeloablative transplants.
-
(2005)
Leuk Lymphoma
, vol.46
, pp. 1251-1260
-
-
Mielcarek, M.1
Storb, R.2
-
2
-
-
0024333302
-
Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts
-
Lapidot T, Terenzi A, Singer TS, et al. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 1989; 73:2025-2032.
-
(1989)
Blood
, vol.73
, pp. 2025-2032
-
-
Lapidot, T.1
Terenzi, A.2
Singer, T.S.3
-
3
-
-
0026539577
-
Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation
-
Uharek L, Gassmann W, Glass B, et al. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992; 79:1612-1621.
-
(1992)
Blood
, vol.79
, pp. 1612-1621
-
-
Uharek, L.1
Gassmann, W.2
Glass, B.3
-
4
-
-
0032558759
-
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
-
Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339:1186-1193.
-
(1998)
N Engl J Med
, vol.339
, pp. 1186-1193
-
-
Aversa, F.1
Tabilio, A.2
Velardi, A.3
-
5
-
-
0033178256
-
Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients
-
Reisner Y, Martelli MF. Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients. Immunol Today 1999; 20:343-347.
-
(1999)
Immunol Today
, vol.20
, pp. 343-347
-
-
Reisner, Y.1
Martelli, M.F.2
-
7
-
-
20644470338
-
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
-
Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005; 23:3447-3454.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3447-3454
-
-
Aversa, F.1
Terenzi, A.2
Tabilio, A.3
-
8
-
-
0032571946
-
Tolerance induction by 'megadose' hematopoietic transplants: Donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture
-
Rachamim N, Gan J, Segall H, et al. Tolerance induction by 'megadose' hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65:1386-1393.
-
(1998)
Transplantation
, vol.65
, pp. 1386-1393
-
-
Rachamim, N.1
Gan, J.2
Segall, H.3
-
10
-
-
20144373526
-
Immune regulatory activity of CD34+ progenitor cells: Evidence for a deletion-based mechanism mediated by TNF-α
-
Gur H, Krauthgamer R, Bachar-Lustig E, et al. Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-α. Blood 2005; 105:2585-2593. Demonstration of the role of death molecules other than FasL in the veto activity of CD34 stem cells.
-
(2005)
Blood
, vol.105
, pp. 2585-2593
-
-
Gur, H.1
Krauthgamer, R.2
Bachar-Lustig, E.3
-
11
-
-
0019205672
-
An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it
-
Miller RG. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 1980; 287:544-546.
-
(1980)
Nature
, vol.287
, pp. 544-546
-
-
Miller, R.G.1
-
12
-
-
0020564323
-
Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens
-
Muraoka S, Miller RG. Cells in murine fetal liver and in lymphoid colonies grown from fetal liver can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Immunol 1983; 131:45-49.
-
(1983)
J Immunol
, vol.131
, pp. 45-49
-
-
Muraoka, S.1
Miller, R.G.2
-
13
-
-
0021717453
-
Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong antiself suppressive activity
-
Claesson MH, Miller RG. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong antiself suppressive activity. J Exp Med 1984; 160:1702-1716.
-
(1984)
J Exp Med
, vol.160
, pp. 1702-1716
-
-
Claesson, M.H.1
Miller, R.G.2
-
14
-
-
0021132017
-
Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes
-
Fink PJ, Rammensee HG, Benedetto JD, et al. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol 1984; 133:1769-1774.
-
(1984)
J Immunol
, vol.133
, pp. 1769-1774
-
-
Fink, P.J.1
Rammensee, H.G.2
Benedetto, J.D.3
-
15
-
-
0021135798
-
Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
-
Fink PJ, Rammensee HG, Bevan MJ. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 1984; 133:1775-1781.
-
(1984)
J Immunol
, vol.133
, pp. 1775-1781
-
-
Fink, P.J.1
Rammensee, H.G.2
Bevan, M.J.3
-
16
-
-
0026777361
-
Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen
-
Zhang LI, Martin DR, Fung-Leung WP, et al. Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992; 148:3740-3745.
-
(1992)
J Immunol
, vol.148
, pp. 3740-3745
-
-
Zhang, L.I.1
Martin, D.R.2
Fung-Leung, W.P.3
-
17
-
-
0028123516
-
Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism
-
Thomas JM, Carver FM, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57:101-115.
-
(1994)
Transplantation
, vol.57
, pp. 101-115
-
-
Thomas, J.M.1
Carver, F.M.2
Kasten-Jolly, J.3
-
18
-
-
0028295821
-
A role for transforming growth factor-beta in the veto mechanism in transplant tolerance
-
Verbanac KM, Carver FM, Haisch CE, Thomas JM. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation 1994; 57:893-900.
-
(1994)
Transplantation
, vol.57
, pp. 893-900
-
-
Verbanac, K.M.1
Carver, F.M.2
Haisch, C.E.3
Thomas, J.M.4
-
19
-
-
0033228366
-
Donor bone marrow and transplantation tolerance: Historical perspectives, molecular mechanisms and future directions
-
George JF, Goldstein DR, Thomas JM. Donor bone marrow and transplantation tolerance: historical perspectives, molecular mechanisms and future directions [review]. Int J Mol Med 1999; 4:475-482.
-
(1999)
Int J Mol Med
, vol.4
, pp. 475-482
-
-
George, J.F.1
Goldstein, D.R.2
Thomas, J.M.3
-
20
-
-
0033680730
-
Antithird party CD8+ CTLs as potent veto cells: Coexpression of CD8 and FasL is a prerequisite
-
Reich-Zeliger S, Zhao Y, Krauthgamer R, et al. Antithird party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity 2000; 13:507-515.
-
(2000)
Immunity
, vol.13
, pp. 507-515
-
-
Reich-Zeliger, S.1
Zhao, Y.2
Krauthgamer, R.3
-
21
-
-
0032899594
-
+ antiviral T cells by viral antigen-positive veto cells
-
+ antiviral T cells by viral antigen-positive veto cells. J Virol 1999; 73:3826-3834.
-
(1999)
J Virol
, vol.73
, pp. 3826-3834
-
-
Rich, R.F.1
Green, W.R.2
-
22
-
-
0025883099
-
Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC
-
Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252:1424-1427.
-
(1991)
Science
, vol.252
, pp. 1424-1427
-
-
Sambhara, S.R.1
Miller, R.G.2
-
23
-
-
0033556785
-
Immunoregulatory role of CD8a in the veto effect: Transforming growth factor-β1 activation
-
Asiedu C, Meng Y, Wang W, et al. Immunoregulatory role of CD8a in the veto effect: transforming growth factor-β1 activation. Transplantation 1999; 67:372-380.
-
(1999)
Transplantation
, vol.67
, pp. 372-380
-
-
Asiedu, C.1
Meng, Y.2
Wang, W.3
-
24
-
-
0029980866
-
Hybrid antibody mediated veto of cytotoxic T lymphocyte responses
-
Qi Y, Berg R, Singleton MA, et al. Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med 1996; 183:1973-1980.
-
(1996)
J Exp Med
, vol.183
, pp. 1973-1980
-
-
Qi, Y.1
Berg, R.2
Singleton, M.A.3
-
25
-
-
0032834109
-
The molecular mechanisms of veto mediated regulation of alloresponsiveness
-
George J, Thomas J. The molecular mechanisms of veto mediated regulation of alloresponsiveness. J Mol Med 1999; 77:519-526.
-
(1999)
J Mol Med
, vol.77
, pp. 519-526
-
-
George, J.1
Thomas, J.2
-
26
-
-
0027382190
-
Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas
-
Cheruku R, Uberti J, Martilotti F, Kaplan J. Generation of lymphokine-activated killer cells with veto and natural suppressor activity from patients with leukemias and lymphomas. Transplantation 1993; 56:1037-1040.
-
(1993)
Transplantation
, vol.56
, pp. 1037-1040
-
-
Cheruku, R.1
Uberti, J.2
Martilotti, F.3
Kaplan, J.4
-
27
-
-
0026547417
-
Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: Implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation
-
Uberti J, Martilotti F, Chou TH, Kaplan J. Human lymphokine activated killer (LAK) cells suppress generation of allospecific cytotoxic T cells: implications for use of LAK cells to prevent graft-versus-host disease in allogeneic bone marrow transplantation. Blood 1992; 79:261-268.
-
(1992)
Blood
, vol.79
, pp. 261-268
-
-
Uberti, J.1
Martilotti, F.2
Chou, T.H.3
Kaplan, J.4
-
28
-
-
9144266371
-
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells
-
Reich-Zeliger S, Bachar-Lustig E, Gan J, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells. J Immunol 2004; 173:6654-6659.
-
(2004)
J Immunol
, vol.173
, pp. 6654-6659
-
-
Reich-Zeliger, S.1
Bachar-Lustig, E.2
Gan, J.3
Reisner, Y.4
-
29
-
-
0031938903
-
An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow
-
George JF, Sweeney SD, Kirklin JK, et al. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 1998; 4:333-335.
-
(1998)
Nat Med
, vol.4
, pp. 333-335
-
-
George, J.F.1
Sweeney, S.D.2
Kirklin, J.K.3
-
30
-
-
9144242988
-
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis
-
Reich-Zeliger S, Gan J, Bachar-Lustig E, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. J Immunol 2004; 173:6660-6666.
-
(2004)
J Immunol
, vol.173
, pp. 6660-6666
-
-
Reich-Zeliger, S.1
Gan, J.2
Bachar-Lustig, E.3
Reisner, Y.4
-
31
-
-
33644825001
-
Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of antiretroviral CTL
-
Rich RF, Cook WJ, Green WR. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of antiretroviral CTL. Virology 2006; 346:287-300. An interesting demonstration of the role of Fas/FasL in veto CTLs presenting viral antigen and thereby deleting antiviral effector cells.
-
(2006)
Virology
, vol.346
, pp. 287-300
-
-
Rich, R.F.1
Cook, W.J.2
Green, W.R.3
-
32
-
-
0033026567
-
T cytotoxic lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape
-
Green WR. T cytotoxic lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape. Immunol Rev 1999; 168:271-286.
-
(1999)
Immunol Rev
, vol.168
, pp. 271-286
-
-
Green, W.R.1
-
33
-
-
0026672304
-
Cyclosporine A and peripheral tolerance: Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes
-
Hiruma K, Gress RE. Cyclosporine A and peripheral tolerance: inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes. J Immunol 1992; 149:1539-1547.
-
(1992)
J Immunol
, vol.149
, pp. 1539-1547
-
-
Hiruma, K.1
Gress, R.E.2
-
34
-
-
33746324887
-
The role of ERK5 signaling in tolerance induction by veto CTLs
-
Reich-Zeliger S, Hanoch T, Seger R, Reisner Y. The role of ERK5 signaling in tolerance induction by veto CTLs [abstract]. Blood 2005; 106:3302.
-
(2005)
Blood
, vol.106
, pp. 3302
-
-
Reich-Zeliger, S.1
Hanoch, T.2
Seger, R.3
Reisner, Y.4
-
35
-
-
0035003410
-
Veto activity of activated bone marrow does not require perforin and Fas ligand
-
Chrobak P, Gress RE. Veto activity of activated bone marrow does not require perforin and Fas ligand. Cell Immunol 2001; 208:80-87.
-
(2001)
Cell Immunol
, vol.208
, pp. 80-87
-
-
Chrobak, P.1
Gress, R.E.2
-
36
-
-
0141567711
-
Antithird-party veto CTLs overcome rejection of hematopoietic allografts: Synergism with rapamycin and BM cell dose
-
Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Antithird-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood 2003; 102:1943-1950.
-
(2003)
Blood
, vol.102
, pp. 1943-1950
-
-
Bachar-Lustig, E.1
Reich-Zeliger, S.2
Reisner, Y.3
-
37
-
-
0035993843
-
Use of calcineurin inhibitors in pediatric liver transplantation: A single-center experience
-
Taylor RM, Cheeseman P, Rela M, et al. Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience. Transplant Proc 2002; 34:1974-1975.
-
(2002)
Transplant Proc
, vol.34
, pp. 1974-1975
-
-
Taylor, R.M.1
Cheeseman, P.2
Rela, M.3
-
38
-
-
33646703806
-
Overcoming T cell mediated rejection of bone marrow allografts by Treg cells: Synergism with veto cells and Rapamycin
-
In press
-
Steiner D, Brunicki N, Bachar-Lustig E. Overcoming T cell mediated rejection of bone marrow allografts by Treg cells: synergism with veto cells and Rapamycin. Exp Hematol 2006; In press.
-
(2006)
Exp Hematol
-
-
Steiner, D.1
Brunicki, N.2
Bachar-Lustig, E.3
-
39
-
-
30344450069
-
Tolerance induction by third-party 'off-the-shelf' CD4+CD25+ Treg cells
-
Steiner D, Brunicki N, Blazar BR, et al. Tolerance induction by third-party 'off-the-shelf' CD4+CD25+ Treg cells. Exp Hematol 2006; 34:66-71.
-
(2006)
Exp Hematol
, vol.34
, pp. 66-71
-
-
Steiner, D.1
Brunicki, N.2
Blazar, B.R.3
-
40
-
-
31044446127
-
Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells
-
Anderson KM, Zimring JC. Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells. Transplantation 2006; 81:88-94. Interesting proposal that rapamycin enhances veto activity by increasing the susceptibility of the effector cells after activation by the relevant stimulator cells.
-
(2006)
Transplantation
, vol.81
, pp. 88-94
-
-
Anderson, K.M.1
Zimring, J.C.2
-
41
-
-
33746328431
-
Effective deletion of anti-donor host memory effector cells by anti3rd party veto CTLs: Implications to tolerance induction in presensitized bone marrow recipients
-
Reich-Zeliger S, Bachar-Lustig E, Reisner Y. Effective deletion of anti-donor host memory effector cells by anti3rd party veto CTLs: implications to tolerance induction in presensitized bone marrow recipients [abstract]. Blood 2004; 104:44.
-
(2004)
Blood
, vol.104
, pp. 44
-
-
Reich-Zeliger, S.1
Bachar-Lustig, E.2
Reisner, Y.3
-
42
-
-
21544444739
-
Large-scale preparation of human antithird-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: A new source for graft facilitating cells in bone marrow transplantation
-
Aviner S, Yao X, Krauthgamer R, et al. Large-scale preparation of human antithird-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. Hum Immunol 2005; 66:644-652. Description of the methodology for generation of human veto CTLs depleted of GVH reactivity.
-
(2005)
Hum Immunol
, vol.66
, pp. 644-652
-
-
Aviner, S.1
Yao, X.2
Krauthgamer, R.3
-
43
-
-
0034067656
-
Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: Considerations for the allogeneic transplantation therapy of leukemia and lymphoma
-
Fowler DH, Gress RE. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000; 38:221-234.
-
(2000)
Leuk Lymphoma
, vol.38
, pp. 221-234
-
-
Fowler, D.H.1
Gress, R.E.2
-
44
-
-
0142214622
-
CD3/CD28-costimulated T1 and T2 subsets: Differential in vivo allosensitization generates distinct GVT and GVHD effects
-
Jung U, Foley JE, Erdmann AA, et al. CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects. Blood 2004; 102:3439-3446.
-
(2004)
Blood
, vol.102
, pp. 3439-3446
-
-
Jung, U.1
Foley, J.E.2
Erdmann, A.A.3
-
45
-
-
4344624106
-
Co-stimulated/Tc2 cells abrogate murine marrow graft rejection
-
Erdmann AA, Jung U, Foley JE, et al. Co-stimulated/Tc2 cells abrogate murine marrow graft rejection. Biol Blood Marrow Transplant 2004; 10:604-613.
-
(2004)
Biol Blood Marrow Transplant
, vol.10
, pp. 604-613
-
-
Erdmann, A.A.1
Jung, U.2
Foley, J.E.3
-
46
-
-
18744415962
-
Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant
-
Fowler D, Hou J, Foley J, et al. Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant. Cytotherapy 2002; 4:429-430.
-
(2002)
Cytotherapy
, vol.4
, pp. 429-430
-
-
Fowler, D.1
Hou, J.2
Foley, J.3
-
47
-
-
1142310696
-
Immunoablative reduced-intensity stem cell transplantation: Potential role of donor Th2 and Tc2 cells
-
Fowler DH, Bishop MR, Gress RE. Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells. Semin Oncol 2004; 31:56-67.
-
(2004)
Semin Oncol
, vol.31
, pp. 56-67
-
-
Fowler, D.H.1
Bishop, M.R.2
Gress, R.E.3
-
48
-
-
0037418284
-
Hematopoiesis-restricted minor histocompatibility antigens HA-1- Or HA-2-specific T cells can induce complete remissions of relapsed leukaemia
-
U S A
-
Marijt WA, Heemskerk MH, Kloosterboer FM, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukaemia. Proc Natl Acad Sci U S A 2003; 100:2742-2747.
-
(2003)
Proc Natl Acad Sci
, vol.100
, pp. 2742-2747
-
-
Marijt, W.A.1
Heemskerk, M.H.2
Kloosterboer, F.M.3
-
49
-
-
0033826798
-
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells
-
Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000; 6:1011-1017.
-
(2000)
Nat Med
, vol.6
, pp. 1011-1017
-
-
Nair, S.K.1
Heiser, A.2
Boczkowski, D.3
|